STORM in the News

BioCentury Emerging Company Profile: Taking RNA epigenetics by storm

STORM Therapeutics Limited is the first company to come out of the budding field of RNA epigenetics, and is targeting RNA-modifying enzymes for cancer.

BioCentury article

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 2021 Dates To be Confirmed

Find out more